Therefore, TalaA is a potential drug candidate that can not only take advantage of the high ROS level to kill cancer cells, but also provides targeted therapy for cancer types with high expression of anti-oxidation molecules such as SLC7A11. The gene discussed is SLC7A11; the disease is cancer.